1. Home
  2. MBINM vs IMNM Comparison

MBINM vs IMNM Comparison

Compare MBINM & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBINM
  • IMNM
  • Stock Information
  • Founded
  • MBINM N/A
  • IMNM 2006
  • Country
  • MBINM United States
  • IMNM United States
  • Employees
  • MBINM 663
  • IMNM N/A
  • Industry
  • MBINM Major Banks
  • IMNM Medicinal Chemicals and Botanical Products
  • Sector
  • MBINM Finance
  • IMNM Health Care
  • Exchange
  • MBINM Nasdaq
  • IMNM Nasdaq
  • Market Cap
  • MBINM N/A
  • IMNM 748.3M
  • IPO Year
  • MBINM N/A
  • IMNM 2020
  • Fundamental
  • Price
  • MBINM $25.03
  • IMNM $8.77
  • Analyst Decision
  • MBINM
  • IMNM Strong Buy
  • Analyst Count
  • MBINM 0
  • IMNM 5
  • Target Price
  • MBINM N/A
  • IMNM $26.40
  • AVG Volume (30 Days)
  • MBINM N/A
  • IMNM 1.1M
  • Earning Date
  • MBINM N/A
  • IMNM 08-11-2025
  • Dividend Yield
  • MBINM N/A
  • IMNM N/A
  • EPS Growth
  • MBINM N/A
  • IMNM N/A
  • EPS
  • MBINM N/A
  • IMNM N/A
  • Revenue
  • MBINM N/A
  • IMNM $10,938,000.00
  • Revenue This Year
  • MBINM N/A
  • IMNM N/A
  • Revenue Next Year
  • MBINM N/A
  • IMNM $310.65
  • P/E Ratio
  • MBINM N/A
  • IMNM N/A
  • Revenue Growth
  • MBINM N/A
  • IMNM N/A
  • 52 Week Low
  • MBINM N/A
  • IMNM $5.15
  • 52 Week High
  • MBINM N/A
  • IMNM $16.81
  • Technical
  • Relative Strength Index (RSI)
  • MBINM 48.98
  • IMNM 49.38
  • Support Level
  • MBINM $24.81
  • IMNM $8.60
  • Resistance Level
  • MBINM $25.18
  • IMNM $9.27
  • Average True Range (ATR)
  • MBINM 0.15
  • IMNM 0.46
  • MACD
  • MBINM 0.01
  • IMNM -0.03
  • Stochastic Oscillator
  • MBINM 60.53
  • IMNM 44.57

About MBINM Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: